Applied DNA Sciences 주식 (NASDAQ: APDN)

에 대한 최신 뉴스 Applied DNA Sciences (NASDAQ:APDN) 주식

Applied DNA Sciences

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

micron-ext-building

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

APDN

수요일(18일) 아침 미국 주식 선물이 상승하고 있는 가운데, 오늘 투자자의 관심을 끌 수 있는 주식은 다음과 같다. 제너럴 밀스, 워딩턴 엔터프라이즈, 자빌, 어플라이드 DNA 및 마이크론

수요일 주목해야 할 주식: 제너럴 밀스, 워딩턴 엔터프라이즈, 자빌, 어플라이드 DNA 및 마이크론

wall-street-ai17

Broad U.S. Equity ETFs

Exclusives

Tech

ETFs

AAPL

AMZN

ASTS

CING

CRWD

GOVX

INDO

LUMN

LUNR

NVDA

PLTR

SERV

SMCI

TSLA

VRAX

ZAPP

매일의 거래일에는 트레이더들이 전체 시장과 개별 종목들에 대한 최신 뉴스를 볼 수 있는 소스인 Benzinga Pro에 수백 개의 헤드라인과 보도 자료가 제공된다. 2024년 8월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식을 살펴보자. 현재 가격과 연간 실적은 8월 30일을 기준으로 하며 배당금은 포함되지 않았다. 4월 검색결과는 추적되지 않았다.

단독: 2024년 8월 벤징가 프로에서 가장 검색량이 많았던 상위 20개 티커는?

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences Inc

Management

Applied DNA Chairperson And CEO James Hayward Retires; Judy Murrah Appointed Chairperson And CEO

<h3>Gainers</h3>
<ul>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares moved upwards by 53.0% to $0.98 during Monday's after-market session. The company's market cap stands at $2.0 million. </li>
<li>Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) shares rose 12.15% to $15.5. The company's market cap stands at $1.7 billion. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares rose 8.59% to $4.8. The company's market cap stands at $43.1 million. </li>
<li>SS Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) shares increased by 8.02% to $3.5. The company's market cap stands at $677.6 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) shares moved upwards by 7.92% to $0.23. The company's market cap stands at $11.0 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock rose 6.3% to $6.58. The company's market cap stands at $179.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>China Pharma Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock fell 8.5% to $1.69 during Monday's after-market session. The market value of their outstanding shares is at $5.5 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) stock declined by 8.34% to $1.21. The company's market cap stands at $18.3 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares declined by 7.86% to $0.35. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock declined by 7.22% to $0.32. The company's market cap stands at $4.0 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock fell 7.22% to $2.96. The market value of their outstanding shares is at $4.8 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock decreased by 6.65% to $4.78. The market value of their outstanding shares is at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BSGM

CLNN

CPHI

DHAI

HSDT

SLRX

SSII

TCRT

VTAK

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) shares rose 37.5% to $9.21 during Monday's pre-market session. The company's market cap stands at $576.7 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares increased by 37.43% to $0.03. The company's market cap stands at $11.3 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares increased by 20.58% to $0.39. The company's market cap stands at $11.8 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares increased by 17.21% to $5.48. The market value of their outstanding shares is at $2.8 million. </li>
<li>HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) shares rose 15.89% to $1.75. The market value of their outstanding shares is at $59.1 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares rose 15.49% to $0.13. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) stock decreased by 39.8% to $21.79 during Monday's pre-market session. The market value of their outstanding shares is at $2.1 billion. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) stock decreased by 11.51% to $1.0. The market value of their outstanding shares is at $33.1 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares fell 11.21% to $0.32. The company's market cap stands at $4.0 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) stock declined by 9.36% to $0.25. The company's market cap stands at $8.4 million. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) stock declined by 7.69% to $1.32. The market value of their outstanding shares is at $23.1 million. </li>
<li>Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) stock fell 7.39% to $0.61. The company's market cap stands at $5.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BEAT

BFRI

CODX

HCTI

IMNN

JUNS

NCNA

ONMD

SAGE

SRPT

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares rose 8.2% to $14.61 during Friday's after-market session. The market value of their outstanding shares is at $211.8 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares rose 6.67% to $0.43. The company's market cap stands at $1.8 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock rose 6.66% to $3.2. The market value of their outstanding shares is at $5.2 million. </li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock rose 6.38% to $1.64. The market value of their outstanding shares is at $27.8 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares increased by 6.25% to $0.82. The company's market cap stands at $27.1 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) stock rose 6.24% to $0.85. The market value of their outstanding shares is at $23.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 22.2% to $4.18 during Friday's after-market session. The company's market cap stands at $2.1 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock decreased by 9.93% to $2.45. The market value of their outstanding shares is at $6.3 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) stock decreased by 9.81% to $0.46. The company's market cap stands at $9.4 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock declined by 9.58% to $22.0. The market value of their outstanding shares is at $572.3 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares decreased by 8.32% to $1.43. The company's market cap stands at $10.7 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares fell 7.48% to $3.96. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABVC

FEMY

GTBP

LIMN

NUWE

OGEN

PTHL

TLPH

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares moved upwards by 91.2% to $24.3 during Thursday's pre-market session. The company's market cap stands at $649.1 million. </li>
<li>Kronos Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>) shares rose 26.65% to $0.85. The company's market cap stands at $52.1 million. </li>
<li>SILO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares increased by 23.69% to $0.71. The company's market cap stands at $5.0 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock rose 22.2% to $770.0. The market value of their outstanding shares is at $10.0 billion. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock rose 16.84% to $6.45. The company's market cap stands at $2.7 million. </li>
<li>Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) shares increased by 12.98% to $0.65. The company's market cap stands at $58.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares fell 76.7% to $0.76 during Thursday's pre-market session. </li>
<li>Cibus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) stock fell 37.29% to $1.48. The company's market cap stands at $48.3 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares declined by 11.8% to $0.46. The company's market cap stands at $7.7 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) shares fell 11.51% to $3.0. The market value of their outstanding shares is at $78.2 million. </li>
<li>Athira Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHA#NASDAQ">ATHA</a>) shares fell 9.1% to $0.3. The market value of their outstanding shares is at $11.7 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) shares fell 8.98% to $0.28. The market value of their outstanding shares is at $17.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATHA

CBUS

CGTX

CNTX

KAPA

KRON

SILO

SNTI

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

WIIM

Applied DNA Sciences shares are trading lower after the company announced a 1-for-15 reverse stock split.

Stock Split

Applied DNA To Effect A 1-For-15 Reverse Stock Split On June 2, 2025

<h3>Gainers</h3>
<ul>
<li>Inozyme Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) stock moved upwards by 178.2% to $3.95 during Friday's regular session. The company's market cap stands at $253.7 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) stock increased by 26.52% to $0.72. The company's market cap stands at $24.2 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>ACADIA Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) shares increased by 25.62% to $22.11. The market value of their outstanding shares is at $3.7 billion. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock moved upwards by 25.47% to $0.28. The company's market cap stands at $40.0 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) stock moved upwards by 25.33% to $1.88. The company's market cap stands at $94.0 million. The company's, Q1 earnings came out yesterday. </li>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) shares increased by 22.8% to $5.43. The market value of their outstanding shares is at $3.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares declined by 67.3% to $0.01 during Friday's regular session. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares fell 22.48% to $0.01. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 19.63% to $0.65. The company's, Q2 earnings came out yesterday. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares fell 18.92% to $0.04. </li>
<li>Lantern Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) stock declined by 18.44% to $3.15. The company's market cap stands at $33.9 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) stock declined by 18.15% to $2.12. The company's market cap stands at $13.0 million. As per the press release, Q3 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACAD

ATPC

AYTU

BDSX

INZY

LTRN

PLRZ

RANI

12 Health Care Stocks Moving In Friday's Intraday Session

Applied DNA Sciences shares are trading lower. The company reported Q2 financial results.

Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) reported quarterly losses of $(15.35) per share. This is a 94.22 percent increase over losses of $(265.45) per share from the same period last year. The company reported $983.37 thousand in sales this quarter. This is a 5.78 percent increase over sales of $929.63 thousand the same period last year.

Applied DNA Sciences Q2 EPS $(15.35) Up From $(265.45) YoY, Sales $983.37K Up From $929.63K YoY

<h3>Gainers</h3>
<ul>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares moved upwards by 68.6% to $0.04 during Monday's regular session. </li>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) stock rose 54.25% to $0.19. The market value of their outstanding shares is at $5.7 million. </li>
<li>Third Harmonic Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRD#NASDAQ">THRD</a>) stock increased by 39.56% to $5.08. The company's market cap stands at $229.1 million. </li>
<li>Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) shares increased by 34.27% to $18.8. The market value of their outstanding shares is at $1.9 billion. </li>
<li>Wellgistics Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>) stock increased by 31.14% to $3.79. The company's market cap stands at $196.8 million. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) stock increased by 29.1% to $0.86. The company's market cap stands at $69.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) stock fell 30.0% to $0.66 during Monday's regular session. The market value of their outstanding shares is at $105.9 million. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock declined by 22.36% to $0.24. The market value of their outstanding shares is at $19.9 million. </li>
<li>Alumis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) shares declined by 21.84% to $5.07. The market value of their outstanding shares is at $275.5 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares decreased by 17.92% to $0.38. The company's market cap stands at $4.2 million. </li>
<li>Bullfrog AI Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRG#NASDAQ">BFRG</a>) shares declined by 17.62% to $1.73. The company's market cap stands at $16.2 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 17.58% to $0.95. The company's market cap stands at $1.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALMS

BFRG

IMAB

IRWD

MTSR

RSLS

STSS

THRD

WGRX

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Monday's Intraday Session

General

Applied DNA Regains Compliance With Nasdaq Minimum Bid Price Requirement

Applied DNA Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares are trading higher by 6.0% to $1.76 during Tuesday&#8217;s session after the company announced it positioned its TR8 PGx testing as <a href="https://www.benzinga.com/pressreleases/25/04/ac44586006/applied-dna-positions-tr8-pgx-testing-service-as-pre-emptive-testing-for-safety-of-fluoropyrimidi">pre-emptive testing</a> for therapeutic safety.
What To Know: Applied DNA Sciences on Tuesday announced that its subsidiary, Applied DNA Clinical Labs (ADCL), is refining its TR8 PGx pharmacogenomics testing service by offering specialized subpanels for specific medical conditions. 
The first subpanel targets patients with DPYD gene variants, which can affect metabolism of chemotherapy drugs fluorouracil (5-FU) and capecitabine (Xeloda), potentially leading to severe toxicities. This move follows an FDA safety notice emphasizing the risks for patients with DPD enzyme deficiencies. 
ADCL's TR8 PGx test, approved in New York, screens for over 33 drug metabolism genes. CEO Dr. James A. Hayward highlighted plans for additional subpanels in oncology, cardiology and psychiatry to enhance clinical decision-making and increase adoption of PGx testing.
Read Also: <a href="https://www.benzinga.com/25/04/44586120/whats-going-on-with-rigetti-computing-stock-today">What&#8217;s Going On With Rigetti Computing Stock Today?</a>
<h2 class="wp-block-heading">How To Buy APDN Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Applied DNA Sciences&#8217; case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, APDN has a 52-week high of $460.00 and a 52-week low of $1.45.

Why Applied DNA Sciences (APDN) Stock Is Rising

Applied DNA Sciences shares are trading higher after the company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety.

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases -

Biotech

Applied DNA Sciences Positions TR8 PGx Testing Service As Pre-Emptive Testing For Safety Of Fluoropyrimidine-Based Cancer Therapeutics Following Publication Of FDA Safety Announcement

<h3>Gainers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock moved upwards by 22.7% to $2.7 during Wednesday's after-market session. The market value of their outstanding shares is at $31.0 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock increased by 15.41% to $0.1. The company's market cap stands at $13.5 million. </li>
<li>Acrivon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRV#NASDAQ">ACRV</a>) shares increased by 11.09% to $2.81. The market value of their outstanding shares is at $87.5 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock increased by 10.41% to $0.53. The market value of their outstanding shares is at $16.0 million. </li>
<li>Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) shares rose 7.94% to $1.9. The company's market cap stands at $135.3 million. The company's, Q4 earnings came out today. </li>
<li>Immunome (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNM#NASDAQ">IMNM</a>) shares rose 7.19% to $7.6. The market value of their outstanding shares is at $660.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock decreased by 20.8% to $0.11 during Wednesday's after-market session. The market value of their outstanding shares is at $2.7 million. </li>
<li>OSR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) stock fell 12.14% to $3.33. The market value of their outstanding shares is at $64.1 million. </li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) stock fell 9.1% to $10.5. The company's market cap stands at $3.1 billion. As per the news, the Q4 earnings report came out today. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares decreased by 8.71% to $0.64. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock fell 8.0% to $1.9. The company's market cap stands at $2.0 million. </li>
<li>SILO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) stock fell 5.84% to $1.28. The company's market cap stands at $5.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACRV

AEON

ALVO

IMNM

OCEA

OSRH

PRPH

PTPI

ZNTL

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) shares rose 14.6% to $1.81 during Wednesday's after-market session. The company's market cap stands at $10.3 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock moved upwards by 11.0% to $2.22. The market value of their outstanding shares is at $2.4 million. </li>
<li>Shuttle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) stock rose 8.43% to $0.45. The market value of their outstanding shares is at $2.2 million. </li>
<li>Century Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) shares moved upwards by 6.36% to $0.62. The market value of their outstanding shares is at $52.7 million. </li>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) shares rose 6.11% to $0.22. The market value of their outstanding shares is at $6.6 million. </li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares moved upwards by 5.7% to $0.38. The company's market cap stands at $38.1 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) shares fell 20.4% to $2.26 during Wednesday's after-market session. The market value of their outstanding shares is at $533.8 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li>Dyadic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) stock declined by 7.54% to $1.35. The market value of their outstanding shares is at $39.9 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock decreased by 6.63% to $0.27. The market value of their outstanding shares is at $1.6 million. </li>
<li>Scienture Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNX#NASDAQ">SCNX</a>) stock declined by 6.32% to $1.78. The company's market cap stands at $15.3 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares declined by 6.03% to $3.05. The market value of their outstanding shares is at $2.0 million. </li>
<li>LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) stock declined by 5.96% to $24.0. The market value of their outstanding shares is at $660.0 million. As per the news, the Q4 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKBA

BCLI

DYAI

FGEN

IPSC

LENZ

SCNX

SHPH

VERO

YCBD

Press Releases

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A  Laboratory-Developed Test

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Akoya Biosciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

Codexis

Champions Oncology

Harvard Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

HC Wainwright & Co.

수요일(18일) 아침 미국 주식 선물이 상승하고 있는 가운데, 오늘 투자자의 관심을 끌 수 있는 주식은 다음과 같다.
1. 제너럴 밀스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>)
제너럴 밀스의 분기 주당순이익은 1.22달러, 매출은 51억 4천만 달러로 예상된다. 주식은 시간외 거래에서 0.3% 하락한 65.75달러에 거래되었다.
2. 워딩턴 엔터프라이즈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>)
화요일에 실적을 발표한 워딩턴 엔터프라이즈의 2분기 실적은 예상치를 상회했다. 주가는 시간외 거래에서 14.3% 상승한 43.66달러에 거래되었다.
3. 자빌 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)
자빌의 분기 주당순이익은 1.88달러, 매출은 66억 1천만 달러로 예상된다. 주식은 시간외 거래에서 0.2% 상승한 134.20달러에 거래되었다.
자세한 내용은 <a href="https://www.benzinga.com/premarket/">프리마켓 커버리지</a>를 확인하세요.
4. 어플라이드 DNA 사이언시스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>)
어플라이드 DNA의 4분기 매출은 예상치를 하회했고, 일부 사업 부문의 매각을 포함한 전략적 구조조정 계획을 발표했다. 주식은 시간외 거래에서 9.6% 하락한 0.2079달러에 거래되었다.
5. 마이크론 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>)
오늘 장 마감 후 실적을 발표할 마이크론의 분기 주당순이익은 1.76달러, 매출은 87억 2천만 달러로 예상된다. 주식은 시간외 거래에서 0.8% 상승한 109.48달러에 거래되었다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%98%AC%ED%95%B4-350-%EA%B8%89%EB%93%B1%ED%95%9C-%ED%8C%94%EB%9E%80%ED%8B%B0%EC%96%B4%EB%8A%94-%EC%BB%AC%ED%8A%B8-%EC%A3%BC%EC%8B%9D/">올해 350% 급등한 팔란티어는 &#8216;컬트 주식&#8217;</a>
사진 제공: 마이크론
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

매일의 거래일에는 트레이더들이 전체 시장과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">개별 종목들</a>에 대한 최신 뉴스를 볼 수 있는 소스인 Benzinga Pro에 수백 개의 헤드라인과 보도 자료가 제공된다.
2024년 8월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식을 살펴보자. 현재 가격과 연간 실적은 8월 30일을 기준으로 하며 배당금은 포함되지 않았다. 4월 검색결과는 추적되지 않았다.
1. 엔비디아 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
&#8211; 현재가: $119.37 
&#8211; 52주 범위: $39.23 ~ $140.76 
&#8211; 연초 대비 수익률: +147.8% 
&#8211; <a href="https://www.benzinga.com/news/earnings/23/02/30713474/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-january-where-do-spy-tesla-apple-and-ford" target="_blank" rel="noopener" data-google-interstitial="false">1월</a>/<a href="https://www.benzinga.com/markets/penny-stocks/23/03/31137326/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-february-including-tesla-apple-and" target="_blank" rel="noopener" data-google-interstitial="false">2월</a>/<a href="https://www.benzinga.com/markets/equities/24/04/38023764/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-march-where-do-tesla-nvidia-spy-and-re" target="_blank" rel="noopener" data-google-interstitial="false">3월</a> 검색 순위: 3위/1위/1위 
&#8211; <a href="https://www.benzinga.com/exclusives/24/06/39234936/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-may-where-do-nvidia-tesla-gamestop-amc-ran" target="_blank" rel="noopener" data-google-interstitial="false">5월</a>/<a href="https://www.benzinga.com/top-stories/24/07/39579249/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-june-where-do-nvidia-gamestop-tesla-apple" target="_blank" rel="noopener" data-google-interstitial="false">6월</a>/<a href="https://www.benzinga.com/top-stories/24/08/40119459/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-july-2024-where-do-tesla-nvidia-apple-crow" target="_blank" rel="noopener" data-google-interstitial="false">7월</a> 검색 순위: 2위/1위/2위
2. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
&#8211; 현재가: $563.68 
&#8211; 52주 범위: $409.22 ~ $565.22 
&#8211; 연초 대비 수익률: +19.3% 
&#8211; 1월/2월/3월 검색 순위: 2위/2위/3위 
&#8211; 5월/6월/7월 검색 순위: 1위/3위/3위
3. 테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
&#8211; 현재가: $214.11 
&#8211; 52주 범위: $138.80 ~ $278.97 
&#8211; 연초 대비 수익률: -13.8% 
&#8211; 1월/2월/3월 검색 순위: 1위/4위/2위 
&#8211; 5월/6월/7월 검색 순위: 4위/4위/1위
4. 슈퍼 마이크로 컴퓨터 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
&#8211; 현재가: $437.70 
&#8211; 52주 범위: $226.59 ~ $1,229.00 
&#8211; 연초 대비 수익률: +53.3% 
&#8211; 1월/2월/3월 검색 순위: 상위 20위 미포함/상위 20위 미포함/5위 
&#8211; 5월/6월/7월 검색 순위: 14위/10위/19위
5. 루멘 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>)
&#8211; 현재가: $5.25 
&#8211; 52주 범위: $0.78 ~ $7.83 
&#8211; 연초 대비 수익률: +17.8% 
&#8211; 1월/2월/3월 검색 순위: 상위 20위 미포함 
&#8211; 5월/6월/7월 검색 순위: 상위 20위 미포함
6. 애플 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
&#8211; 현재가: $229.00 
&#8211; 52주 범위: $164.08 ~ $237.23 
&#8211; 연초 대비 수익률: +23.4% 
&#8211; 1월/2월/3월 검색 순위: 5위/8위/4위 
&#8211; 5월/6월/7월 검색 순위: 6위/5위/7위
7. 팔란티어 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)
&#8211; 현재가: $31.48 
&#8211; 52주 범위: $13.68 ~ $33.12 
&#8211; 연초 대비 수익률: +89.9% 
&#8211; 1월/2월/3월 검색 순위: 상위 20위 미포함/상위 20위 미포함/11위 
&#8211; 5월/6월/7월 검색 순위: 6위/5위/7위
8. 어드밴스드 마이크로 디바이시스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)
&#8211; 현재가: $148.56 
&#8211; 52주 범위: $93.12 ~ $227.30 
&#8211; 연초 대비 수익률: +7.2% 
&#8211; 1월/2월/3월 검색 순위: 12위/14위/8위 
&#8211; 5월/6월/7월 검색 순위: 8위/9위/4위
9. Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
&#8211; 현재가: $476.27 
&#8211; 52주 범위: $342.35 ~ $503.52 
&#8211; 연초 대비 수익률: +18.3% 
&#8211; 1월/2월/3월 검색 순위: 18위/상위 20위 미포함/9위 
&#8211; 5월/6월/7월 검색 순위: 9위/11위/11위
10. 지오백스 랩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>)
&#8211; 현재가: $4.63 
&#8211; 52주 범위: $1.09 ~ $11.18 
&#8211; 연초 대비 수익률: -16.6% 
&#8211; 1월/2월/3월 검색 순위: 상위 20위 미포함 
&#8211; 5월/6월/7월 검색 순위: 상위 20위 미포함
주목할 만한 종목들: 다음 주식들은 2024년 상반기에 Benzinga Pro에서 11위에서 20위까지 가장 많이 검색된 종목들이었다.
11. 인도네시아 에너지 코퍼레이션 (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INDO#AMEX">INDO</a>)
12. 바이랙스 바이오랩스 그룹 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>)
13. 아마존닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)
14. 싱귤레이트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>)
15. 메타 플랫폼스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
16. 서브 로보틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>)
17. 어플라이드 DNA 사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>)
18. AST 스페이스모바일 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>)
19. 크라우드스트라이크 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)
20. 인튜이티브 머신스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>)
중요한 이유 (Why It&#8217;s Important): 엔비디아는 해당 월 동안 <a href="https://www.benzinga.com/news/earnings/24/08/40613050/nvidia-q2-earnings-guidance-top-street-view-as-ai-fuels-record-data-center-revenue-gross-margin-fal" target="_blank" rel="noopener" data-google-interstitial="false">분기별 실적 발표</a>가 있어서 8월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식이었다. 이 회사는 분석가들의 추정치를 웃돌았고, 추정치보다 앞선 지침을 공유했다. 해당 주식은 올해 매달 Benzinga Pro에서 가장 많이 검색된 상위 3개 종목 중 하나로 꾸준히 선정되었다.
7월 1위를 차지했던 테슬라는 8월 3위로 떨어졌다. 이 전기 자동차 주식은 2024년 동안 매달 가장 많이 검색된 4개 종목 중 하나로 선정되었다.
8월에는 두 개의 ETF가 가장 많이 검색된 종목 중 하나였으며 SPY가 2위, QQQ가 9위를 차지했다. S&amp;P 500을 추적하는 SPY는 매월 가장 많이 검색되는 상위 3개 종목 중 하나로 정기적으로 선정되었다. 나스닥 100을 추적하는 QQQ는 8월 상승세를 보이며 5월 이후 처음으로 다시 톱 10에 진입했다.
슈퍼 마이크로 컴퓨터는 8월에 <a href="https://www.benzinga.com/trading-ideas/short-ideas/24/08/40579899/super-micro-computer-stock-falls-on-short-report-hindenburg-says-company-has-accounting" target="_blank" rel="noopener">공매도 보고서</a>와 회사의 업데이트로 인해 관심이 급증한 것으로 보인다. 지난 3월 5위까지 올랐던 주가는 8월 4위를 기록했다. 주가는 6월 10위 이후 처음으로 다시 10위권 안으로 진입했다.
신규 주식 두 종목이 상위 10개 종목 목록에 합류했으며, 루멘 테크놀로지스는 5위, 지오백스 랩스는 10위를 차지했다. 루멘은 이번 달 <a href="https://www.benzinga.com/news/24/08/40221474/lumen-technologies-stock-continues-to-soar-whats-going-on" target="_blank" rel="noopener">분기별 재무 결과를 발표</a>한 후 주가가 급등하고 투자자들의 관심을 받았다. 지오백스 랩스는 엠폭스(mpox, 원숭이두창)에 대한 세계보건기구(WHO)의 <a href="https://www.benzinga.com/general/health-care/24/08/40381585/who-declares-mpox-public-health-emergency-coordinated-international-response-essential-to-hal" target="_blank" rel="noopener">긴급 보건 선언</a>과 관련하여 높은 변동성과 관심 증가를 확인했다. 지오백스 랩스에는 엠폭스에 효과적이라고 알려진 백신이 있다.
상위 10위권에는 8월 16위를 차지한 서브 로보틱스와 8월 상위 20위 안에 들지 못한 잽 전기차 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>)이 포함되었다.
iShares Russell 2000 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>)는 독자들의 지속적인 관심을 받고 있다. 소형주를 추적하는 이 ETF는 7월 22위에 이어 8월에는 24위에 올랐다. 잠재적인 연방준비제도의 금리 인하가 임박함에 따라 9월에는 소형주와 ETF에 대한 관심이 높아질 수 있다.
Photo created using artificial intelligence via MidJourney.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Applied DNA Sciences

뉴스

에 대한 최신 뉴스 Applied DNA Sciences (NASDAQ:APDN) 주식

수요일, 12월 18, 2024

수요일, 9월 04, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌